(Total Views: 365)
Posted On: 06/04/2019 10:21:41 AM
Post# of 36567
I doubt that anyone missed yesterday's PR. However, just in case, or if you read it quickly, check out this agenda for the CC. It's extremely ambitious.
Generex shareholder dividend follow-up
Launch of FDA Cleared Excellagen® for Wound Management by subsidiary Olaregen Therapeutix
Update on NuGenerex Immuno-Oncology Spin-out and dividend shares
Pending completion of acquisitions:
° Pantheon Medical and MediSource Partners
Plans to start NuGenerex Health, an HMO with Dr. Kiran Patel and Sanjay Kumar
Plans to establish NuGenerex Chronic Care Solutions with Sanjay Kumar
S1 Filing and financing initiatives
Application for up-list to national exchange
Conference call scheduled for June 21st, 2019
Generex shareholder dividend follow-up
Launch of FDA Cleared Excellagen® for Wound Management by subsidiary Olaregen Therapeutix
Update on NuGenerex Immuno-Oncology Spin-out and dividend shares
Pending completion of acquisitions:
° Pantheon Medical and MediSource Partners
Plans to start NuGenerex Health, an HMO with Dr. Kiran Patel and Sanjay Kumar
Plans to establish NuGenerex Chronic Care Solutions with Sanjay Kumar
S1 Filing and financing initiatives
Application for up-list to national exchange
Conference call scheduled for June 21st, 2019
(0)
(0)
